
    
      Patients with carcinoma of the esophagus not suitable for definitive radical treatment who
      have symptomatic dysphagia requiring locoregional palliation, and who have no
      contra-indications to chemo-radiotherapy will be offered Carboplatin (AUC 2) and paclitaxel
      (50 mg/m2) intravenously on days 1 and 8 concurrent with external beam radiation therapy of
      30Gy/10 fractions over two weeks where the primary goal is relief of dysphagia and other
      outcomes include toxicity, quality of life and metabolomics.
    
  